Over the past decade, growing evidence has confirmed the role of essential trace metals in the onset and progression of AD, particularly implicating excess “free” copper—defined as the fraction of serum copper that is not bound to proteins, which is primarily ceruloplasmin (CP), and known also as non-ceruloplasmin copper—and abnormal iron deposition in cognitive decline [17,18]. This evidence concerns the gene CP and Alzheimer disease.